Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Re-Org Makes Chief Of Staff Liaison Between Centers And Commissioner

Executive Summary

A newly created FDA Office of the Chief of Staff will serve as the major point of contact between FDA centers and offices, and the Commissioner, according to an Aug. 30 Federal Register notice

You may also be interested in...



FDA Chief Of Staff Barclay Hails From Agency, By Way Of M Street

Lisa Barclay returns to government from Zuckerman Spaeder where she co-authored a report urging more regulation of nutritional supplements based on nanotechnology.

FDA Chief Of Staff Barclay Hails From Agency, By Way Of M Street

Lisa Barclay returns to government from Zuckerman Spaeder where she co-authored a report urging more regulation of nutritional supplements based on nanotechnology.

FDA Reorganization Adds "Directorate" Layer, But Sharpens Agency's Focus

Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the drug and biologic review centers intact but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.

Related Content

UsernamePublicRestriction

Register

PS048744

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel